AOL

Merck to test single-dose regimen of HPV vaccine Gardasil 9

(Reuters) - Merck & Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the efficacy and safety of a single-dose regimen ...
MarketWatch

Single-use Technologies for Biopharmaceuticals Market to 2029 with Sartorius, Danaher, Merck, and Thermo Fisher Scientific Leading the $11.2 Billion Industry ...

The "Single-use Technologies for Biopharmaceuticals Market" report has been added to ResearchAndMarkets.com's offering. The Single-use Technologies for Biopharmaceuticals was valued at USD 6.5 billion ...
Business Wire

Merck Announces Topline Results from Pivotal Phase 3 Trials Evaluating Investigational, Once-Daily, Oral, Two-Drug, Single-Tablet Regimen of Doravirine/Islatravir (DOR/ISL) for ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline results from two pivotal Phase 3 trials of the investigational, ...
Kalkine Media

Merck Stock In Focus As Combination Therapies Shape Healthcare

Merck remains in focus as combination therapy development and pipeline progress shape the broader healthcare landscape.
Yahoo

Merck to test single-dose regimen of HPV vaccine Gardasil 9

Add Yahoo as a preferred source to see more of our stories on Google. Signage is seen at the Merck & Co. headquarters in Kenilworth, New Jersey (Reuters) - Merck & Co said on Wednesday it plans to ...